Comparison Overview
Novartis Gene Therapies
Novartis Gene Therapies
2275 Half Day Road, Bannockburn, llinois , 60015, US
Last Update: 28/03/2026
Novartis Gene Therapies (formerly AveXis) is reimagining medicine to transform the lives of people living with rare genetic diseases. Utilizing cutting-edge technology, we are working to turn promising gene therapies into proven treatments, beginning with our transforma...
Charles River Laboratories
251 Ballardvale Street, Wilmington, Massachusetts, US, 01887
Last Update: 31/03/2026
At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of ou...
Compliance Ranges Comparison
Novartis Gene Therapies
Charles River Laboratories
Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Novartis Gene Therapies in 2026.
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Charles River Laboratories in 2026.
Incident History - Novartis Gene Therapies (X = Date, Y = Severity)
Novartis Gene Therapies cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Charles River Laboratories (X = Date, Y = Severity)
Charles River Laboratories cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
Novartis Gene Therapies
Charles River Laboratories
FAQ
Latest Global CVEs
A vulnerability was determined in Comfast CF-WR631AX V3 up to 2.7.0.8. Affected by this vulnerability is the function system_wl_upload_pic_file of the file /usr/bin/webmgnt of the component FastCGI Backend. This manipulation of the argument filename causes os command injection. It is possible to initiate the attack remotely. The exploit has been publicly disclosed and may be utilized. The vendor was contacted early about this disclosure but did not respond in any way.
A vulnerability was found in Leantime up to 3.8.0. Affected is the function Setting::saveSetting of the component API. The manipulation results in improper authorization. The attack may be performed from remote. The exploit has been made public and could be used. The vendor was contacted early about this disclosure but did not respond in any way.
A vulnerability has been found in Leantime up to 3.8.0. This impacts the function editUser/addUser of the component JSON-RPC Endpoint. The manipulation of the argument role leads to improper authorization. The attack is possible to be carried out remotely. The exploit has been disclosed to the public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.
A flaw has been found in Helicone ai-gateway up to 0.2.0-beta.30. This affects the function build_target_url of the file ai-gateway/src/dispatcher/service.rs of the component AWS Metadata Service. Executing a manipulation of the argument extracted_path_and_query can lead to server-side request forgery. The attack can be executed remotely. The exploit has been published and may be used. The vendor was contacted early about this disclosure but did not respond in any way.
A vulnerability was detected in coollabsio Coolify up to 4.1.1. The impacted element is an unknown function of the file /app/Policies/ of the component Policy Handler. Performing a manipulation results in missing authorization. Remote exploitation of the attack is possible. The exploit is now public and may be used.